Ablatus Therapeutics

info@ablatus.co.uk

Contact Us

You can contact us by email info@ablatus.co.uk

Click here to ensure you receive the latest updates from Ablatus

Click here to learn more about BETA

Our technology, Bimodal Electric Tissue Ablation (BETA) is next-generation radiofrequency ablation offering larger, more effective ablations with potentially fewer adverse events and at lower cost than RFA.

4 Jul
Healthcare revolution: The ten health innovations that could soon be on the NHS

In the 70 years since the NHS was established, medical breakthroughs such… | Read more
11 Jun
Award nomination for New Anglia Capital investee Ablatus

Norfolk and Norwich University Hospital spin-out Ablatus Therapeutics has been shortlisted for… | Read more
6 Jun
Breaking down the barriers

Despite the Governments recent Accelerated Access Review – barriers to adoption of… | Read more
29 May
NVM Private Equity leads investment in Ablatus Therapeutics

NVM Private Equity (“NVM”) has invested £1.0 million of growth capital into… | Read more
3 May
East Anglia’s angel investor fund has been given a £1m top-up to support young businesses

A venture capital fund backing some of the region’s high-growth business prospects… | Read more